key: cord-0772514-q39dm0x4 authors: Wu, Mary; Wall, Emma C; Carr, Edward J; Harvey, Ruth; Townsley, Hermaleigh; Mears, Harriet V; Adams, Lorin; Kjaer, Svend; Kelly, Gavin; Warchal, Scott; Sawyer, Chelsea; Kavanagh, Caitlin; Queval, Christophe J; Ngai, Yenting; Hatipoglu, Emine; Ambrose, Karen; Hindmarsh, Steve; Beale, Rupert; Gamblin, Steve; Howell, Michael; Kassiotis, George; Libri, Vincenzo; Williams, Bryan; Gandhi, Sonia; Swanton, Charles; Bauer, David LV title: Three-dose vaccination elicits neutralising antibodies against omicron date: 2022-01-19 journal: Lancet DOI: 10.1016/s0140-6736(22)00092-7 sha: 725ecf39dbb317317ee456a22ab69e71105c8d81 doc_id: 772514 cord_uid: q39dm0x4 nan , 1D, and 1E. (See Table 2 for data relating to Figure 1C .) Figure 1B ) (Refers to Figure 1D ) (Refers to Figure 1E ) Table 3 , below). No 0 (0%) 0 (0%) 5 (11%) 2 (8.7%) (n.d.) 0 (0%) 0 (0%) 0 (0%) 2 (8.7%) … vs. Delta Yes 147 (99%) 51 (100%) 33 (73%) 19 (83%) No 1 (0.7%) 0 (0%) 12 (27%) 2 (8.7%) (n.d.) 0 (0%) 0 (0%) 0 (0%) 2 (8.7%) … Two prospective cohorts of Legacy participants were established in January 2021 (NCT04750356). Participants were included if they were an employee of either UCLH or the Sera from participants were analysed by participants' vaccine dose number, date since vaccine dose, presence of prior COVID symptoms, experience of "breakthrough" infection following second vaccine dose, and age. The SARS-CoV-2 B. T95I, Δ142-144, Y145D, Δ211, L212I, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, A701V, N764K, D796Y, N856K, Supernatant was aliquoted and frozen at -80°C. All virus stocks generated for use in neutralisation assays were sequence-validated prior to use. To confirm the identity of the cultured Omicron VOC, Sanger sequencing was used. For Alpha and Delta VOCs, 8ul of viral RNA was prepared for sequencing by the ARTIC method genomically-confirmed-case-numbers/variants-distribution-of-case-data-2-july-2021) were used to assign the likely variant (Alpha or Delta) that caused breakthrough infection. High-throughput live virus microneutralisation assays were performed as described antibody produced in-house and cellular DNA using DAPI 7 . Whole-well imaging at 5x was carried out using an Opera Phenix (Perkin Elmer) and fluorescent areas and intensity calculated using the Phenix-associated software Harmony (Perkin Elmer). Inhibition was estimated from the measured area of infected cells/total area occupied by all cells. The inhibitory profile of each serum sample was estimated by fitting a 4-parameter dose response curve executed in SciPy. Neutralising antibody titres are reported as the fold-dilution of serum required to inhibit 50% of viral replication (IC 50 ), and are further annotated if they lie above the quantitative (complete inhibition) range, below the quantitative range but still within the qualitative range (i.e. partial inhibition is observed but a dose-response curve cannot be fit because it does not sufficiently span the IC 50 ), or if they show no inhibition at all. Study data were collected and managed using REDCap electronic data capture tools hosted values above the quantitative limit of detection of the assay (>2560) were recoded as 5120; IC50 values below the quantitative limit of the assay (< 40) but within the qualitative range were recoded as 10; data below the qualitative range (i.e. no response observed) were recoded as 5. These changes do not affect any statistical parameters considered in the quantitative analyses below (i.e. non-parametric approaches, rather than parametric approaches such as geometric means are used, and these winsorized values lie outside the median and IQR). • Data analysis was carried out using the dplyr package in R. Summary descriptions of the clinical cohort and of measured NAbTs were generated using the gtsummary package in R and its tbl_summary function, specifying calculation of median and IQR for continuous variables using the argument statistic = all_continuous() ~ "{median} • The 95% confidence interval for the median fold-difference of serum viral neutralisation IC 50 between different variants following two-dose vaccination was determined using bootstrap statistics, implemented in R using the infer package using the generate function, specifying the type = "bootstrap" and reps = 5000 arguments, and get_confidence_interval function, without modification of their default parameters. Where a fold-change could not be calculated due to missing paired data across variants, samples were excluded from paired analysis (see Tables 1-3 , "n.d."). • The number of sera that did (or did not) have a quantifiable NAbT of Alpha or Delta vs. Omicron was assessed for statistical significance using Pearson's Chi-squared test with Yates' continuity correction, implemented by the chisq.test function in the R stats package, without modification of its default parameters. • The same method was used to assess the significance of the number of sera that did (or did not) have a quantifiable NAbT against Omicron between those who did (or did not) report experiencing prior COVID symptoms, in the cohort of AZD1222 recipients sampled 2-6 weeks following their second vaccine dose. • The difference in NAbTs between sera from BNT162b2 recipients sampled 2-6 weeks following their second vaccine dose who did (or did not) report experiencing prior COVID symptoms, was assessed for statistical significance using the Wilcoxon rank sum test with continuity correction, implemented by the wilcox.test function, specifying the paired = FALSE argument, in the R stats package, without modification of its default parameters. • The 95% confidence interval for the median fold-difference of serum viral neutralisation IC 50 between different variants following three-dose vaccination was determined as described above for two-dose vaccination. • The 95% confidence interval for the fold-increase in the median serum viral neutralisation IC 50 of two-dose vs. three-dose recipients (unpaired), in older BNT162b2 participants (>= 45 yrs), was determined using bootstrap statistics using the boot package in in R, specifying rep=5000 and strata arguments for the boot function, and the type="basic" and conf=0.95 arguments for the boot.ci function, without further modification of their default parameters. Graphs for participant neutralisation titres were generated using the ggplot2 package in R, Venn diagrams illustrating the overlap between serum sampling and unique participants were generated using the ggvenn package in R, and graphs for monoclonal antibody neutralisation were generated in Prism (GraphPad). All data (anonymised) and full R code to produce all figures and statistical analysis presented in this manuscript are freely-available online on Github: https://github.com/davidlvb/Crick-UCLH-Legacy-Omicron-2021-12 The Legacy study was approved by London Camden and Kings Cross Health Research Authority (HRA) Research and Ethics committee (REC) IRAS number 286469 and sponsored by University College London. as well as by the UK Research and Innovation and the UK Medical Research Council Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus The REDCap consortium: Building an international community of software platform partners Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support This research was funded in whole, or in part, by the Wellcome Trust [FC011104, FC011233, This work was undertaken at UCLH/UCL who received a proportion of funding from the